BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3268925)

  • 1. [Evaluation of the specific immune response after anti-rubella vaccination].
    Cellesi C; Rossolini A; Rossolini GM; Bianchi Bandinelli ML; Cusi MG; Egisto Valensin P
    Quad Sclavo Diagn; 1988; 24(1-4):97-105. PubMed ID: 3268925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
    Braito A; Fanti O; Rossolini GM; Cellesi C
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):443-8. PubMed ID: 1670047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postpartum immunization with rubella virus vaccine and antibody response in breast-feeding infants.
    Krogh V; Duffy LC; Wong D; Rosenband M; Riddlesberger KR; Ogra PL
    J Lab Clin Med; 1989 Jun; 113(6):695-9. PubMed ID: 2732617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies of the immunogenic and reactogenic properties of various vaccines against rubella. I. Seroconversion and post-vaccination reactions in girls immunized against rubella with Almevax vaccine].
    Kańtoch M; Rudnicka H; Imbs D
    Przegl Epidemiol; 1985; 39(3-4):301-8. PubMed ID: 3832164
    [No Abstract]   [Full Text] [Related]  

  • 7. Rubella epidemiology over a 14-year period in Siena (Italy): a retrospective serological survey.
    Valensin PE; Cusi MG; Zanchi A; Rossolini GM; Cellesi C; Amato T
    Microbiologica; 1988 Apr; 11(2):119-27. PubMed ID: 3405097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA and the rubella-specific immune response following vaccination.
    Van Eden W; UytdeHaag F; Loggen HG; Plantinga AD; De Vries RR; Van Rood JJ
    Exp Clin Immunogenet; 1984; 1(2):70-4. PubMed ID: 6400993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella immunization of teenage girls in Iceland and follow-up after a severe rubella epidemic.
    Rafnar B
    Bull World Health Organ; 1982; 60(1):141-6. PubMed ID: 6979417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prepuberal rubella vaccination and development of antibodytiters during five years (author's transl)].
    Müller G; Baumann H
    Padiatr Padol; 1978; 13(3):291-7. PubMed ID: 673433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials carried out to assess non-parenteral routes for administration of Wistar RA 27/3 strain live attenuated rubella vaccine.
    Freestone DS
    Dev Biol Stand; 1976; 33():237-40. PubMed ID: 782973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on live rubella vaccine. VI. Seroepidemiological surveillance and immunization of adolescents in high school.
    Minekawa Y; Takahashi M; Ueda S; Ogino T
    Biken J; 1975 Sep; 18(3):149-54. PubMed ID: 1191245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiologic situation of rubella in Italy 20 years after the introduction of the vaccine].
    Galli MG
    Ann Ig; 1989; 1(1-2):247-54. PubMed ID: 2483071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the immune status in a female population sample 10 years after rubella vaccination].
    Becchi A; Fornero M; Mantovani G
    Nuovi Ann Ig Microbiol; 1985; 36(4):305-11. PubMed ID: 3842769
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.